Lisanti Small Cap Growth Fund ASCGX

Morningstar Medalist Rating
  • NAV / 1-Day Return$22.94  /  −2.51%
  • Fund Size$13.2M
  • Adjusted Expense Ratio3.060%
  • Net Expense Ratio1.740%
  • Fee Level: DistributionHigh
  • Share Class TypeNo Load
  • Morningstar CategorySmall Growth
  • Equity Style Box (Funds)Small Growth
  • Minimum Initial Investment$100
  • Investment StatusOpen
  • TTM Yield0.00%
  • Turnover Ratio358%

Morningstar’s Analysis ASCGX

Will ASCGX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Lisanti Small Cap Growth holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ASCGX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings22.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Corcept Therapeutics Inc

2.77422,318
Healthcare

Kiniksa Pharmaceuticals International PLC Class A

2.58393,568
Healthcare

Hinge Health Inc Ordinary Shares - Class A

2.52384,098
Healthcare

Magnite Inc

2.47376,879
Communication Services

CareDx Inc

2.12323,375
Healthcare

HeartFlow Inc

2.07316,659
Healthcare

Zeta Global Holdings Corp Class A

2.03310,017
Technology

Guardian Pharmacy Services Inc Class A Shares

1.96298,714
Healthcare

Glaukos Corp

1.95297,184
Healthcare

First American Treasury Obligs Z

1.94296,918
Cash and Equivalents

Sponsor Center